Cisplatinum and interstitial laser therapy for advanced head and neck cancer: A preclinical study

M. B. Paiva; R. E. Saxton; Q. M. VanderWerf; T. Bell; A. A. Eshraghi; I. P. Graeber; J. Feyh; D. J. Castro

doi:10.1002/(SICI)1096-9101(1997)21:5<423::AID-LSM3>3.0.CO;2-S

Cisplatinum and interstitial laser therapy for advanced head and neck cancer: A preclinical study

M. B. Paiva, R. E. Saxton, Q. M. VanderWerf, T. Bell, A. A. Eshraghi, I. P. Graeber, J. Feyh, D. J. Castro

Research output: Contribution to journal › Article

12 Scopus citations

Abstract

Background and Objective: Direct intratumor injection of cisplatinum (CDDP) and laser therapy were tested for improved treatment of squamous cell carcinoma (SCCA). Study Design/Materials and Methods: Human SCCA tumors were grown as se transplants in nude mice and injected with CDDP (0.4-1.2 mg/gm) in water or in collagen-based gel carrier with epinephrine (epi-gel), followed by interstitial laser therapy (ILT) via 0.6 mm fiberoptics (532 nm/300J). Results: Tumors injected with CDDP epi-gel exhibited a partial response with 2-4-fold tumor growth delay, compared to aqueous drug or untreated SCCA transplants during 10-week follow-up. Combined drug and laser therapy significantly decreased tumor volume with recurrence in only 25% (2/8) of animals tested, compared to 66% tumor regrowth (10/15) after ILT alone. Conclusion: These initial results suggest laser chemotherapy may become an effective treatment for advanced head and neck cancer.

Original language	English (US)
Pages (from-to)	423-431
Number of pages	9
Journal	Lasers in Surgery and Medicine
Volume	21
Issue number	5
DOIs	https://doi.org/10.1002/(SICI)1096-9101(1997)21:5<423::AID-LSM3>3.0.CO;2-S
State	Published - Nov 20 1997
Externally published	Yes

Keywords

Cisplatinum
Interstitial laser therapy
Squamous cell carcinoma

ASJC Scopus subject areas

Surgery

Access to Document

10.1002/(SICI)1096-9101(1997)21:5<423::AID-LSM3>3.0.CO;2-S

Fingerprint Dive into the research topics of 'Cisplatinum and interstitial laser therapy for advanced head and neck cancer: A preclinical study'. Together they form a unique fingerprint.

Cite this

Paiva, M. B., Saxton, R. E., VanderWerf, Q. M., Bell, T., Eshraghi, A. A., Graeber, I. P., Feyh, J., & Castro, D. J. (1997). Cisplatinum and interstitial laser therapy for advanced head and neck cancer: A preclinical study. Lasers in Surgery and Medicine, 21(5), 423-431. https://doi.org/10.1002/(SICI)1096-9101(1997)21:5<423::AID-LSM3>3.0.CO;2-S

@article{713402850789460fb7e841830bbe5c75,

title = "Cisplatinum and interstitial laser therapy for advanced head and neck cancer: A preclinical study",

abstract = "Background and Objective: Direct intratumor injection of cisplatinum (CDDP) and laser therapy were tested for improved treatment of squamous cell carcinoma (SCCA). Study Design/Materials and Methods: Human SCCA tumors were grown as se transplants in nude mice and injected with CDDP (0.4-1.2 mg/gm) in water or in collagen-based gel carrier with epinephrine (epi-gel), followed by interstitial laser therapy (ILT) via 0.6 mm fiberoptics (532 nm/300J). Results: Tumors injected with CDDP epi-gel exhibited a partial response with 2-4-fold tumor growth delay, compared to aqueous drug or untreated SCCA transplants during 10-week follow-up. Combined drug and laser therapy significantly decreased tumor volume with recurrence in only 25% (2/8) of animals tested, compared to 66% tumor regrowth (10/15) after ILT alone. Conclusion: These initial results suggest laser chemotherapy may become an effective treatment for advanced head and neck cancer.",

keywords = "Cisplatinum, Interstitial laser therapy, Squamous cell carcinoma",

author = "Paiva, {M. B.} and Saxton, {R. E.} and VanderWerf, {Q. M.} and T. Bell and Eshraghi, {A. A.} and Graeber, {I. P.} and J. Feyh and Castro, {D. J.}",

year = "1997",

month = nov,

day = "20",

doi = "10.1002/(SICI)1096-9101(1997)21:5<423::AID-LSM3>3.0.CO;2-S",

language = "English (US)",

volume = "21",

pages = "423--431",

journal = "Lasers in Surgery and Medicine",

issn = "0196-8092",

publisher = "Wiley-Liss Inc.",

number = "5",

}

TY - JOUR

T1 - Cisplatinum and interstitial laser therapy for advanced head and neck cancer

T2 - A preclinical study

AU - Paiva, M. B.

AU - Saxton, R. E.

AU - VanderWerf, Q. M.

AU - Bell, T.

AU - Eshraghi, A. A.

AU - Graeber, I. P.

AU - Feyh, J.

AU - Castro, D. J.

PY - 1997/11/20

Y1 - 1997/11/20

N2 - Background and Objective: Direct intratumor injection of cisplatinum (CDDP) and laser therapy were tested for improved treatment of squamous cell carcinoma (SCCA). Study Design/Materials and Methods: Human SCCA tumors were grown as se transplants in nude mice and injected with CDDP (0.4-1.2 mg/gm) in water or in collagen-based gel carrier with epinephrine (epi-gel), followed by interstitial laser therapy (ILT) via 0.6 mm fiberoptics (532 nm/300J). Results: Tumors injected with CDDP epi-gel exhibited a partial response with 2-4-fold tumor growth delay, compared to aqueous drug or untreated SCCA transplants during 10-week follow-up. Combined drug and laser therapy significantly decreased tumor volume with recurrence in only 25% (2/8) of animals tested, compared to 66% tumor regrowth (10/15) after ILT alone. Conclusion: These initial results suggest laser chemotherapy may become an effective treatment for advanced head and neck cancer.

AB - Background and Objective: Direct intratumor injection of cisplatinum (CDDP) and laser therapy were tested for improved treatment of squamous cell carcinoma (SCCA). Study Design/Materials and Methods: Human SCCA tumors were grown as se transplants in nude mice and injected with CDDP (0.4-1.2 mg/gm) in water or in collagen-based gel carrier with epinephrine (epi-gel), followed by interstitial laser therapy (ILT) via 0.6 mm fiberoptics (532 nm/300J). Results: Tumors injected with CDDP epi-gel exhibited a partial response with 2-4-fold tumor growth delay, compared to aqueous drug or untreated SCCA transplants during 10-week follow-up. Combined drug and laser therapy significantly decreased tumor volume with recurrence in only 25% (2/8) of animals tested, compared to 66% tumor regrowth (10/15) after ILT alone. Conclusion: These initial results suggest laser chemotherapy may become an effective treatment for advanced head and neck cancer.

KW - Cisplatinum

KW - Interstitial laser therapy

KW - Squamous cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0030772925&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030772925&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-9101(1997)21:5<423::AID-LSM3>3.0.CO;2-S

DO - 10.1002/(SICI)1096-9101(1997)21:5<423::AID-LSM3>3.0.CO;2-S

M3 - Article

C2 - 9365952

AN - SCOPUS:0030772925

VL - 21

SP - 423

EP - 431

JO - Lasers in Surgery and Medicine

JF - Lasers in Surgery and Medicine

SN - 0196-8092

IS - 5

ER -